Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
Moisturisers beneficial for eczema
Vault Navigation
Moisturisers beneficial for eczema
How effective are moisturisers for patients with eczema?
Most moisturisers showed some beneficial effects, producing better results when used with active treatment, prolonging time to flare, and reducing the number of flares and amount of topical corticosteroid needed to achieve similar reductions in eczema severity. Participants considered moisturisers more than twice as effective in improving eczema than placebo, vehicle or no moisturiser. There was no difference in the number of adverse events reported. There was no evidence that one moisturiser was better than another.
There was high-certainty evidence for physician assessments of disease severity comparing glycerol-containing creams with control and “all moisturisers versus control”. For most other outcomes in the various comparisons, there was low to moderate-certainty evidence. The most important reasons for lowering the certainty of evidence were risk of bias in the studies (eg, no blinding or missing data) or too few participants leading to less-precise results.
Eczema is a chronic disease characterised by dry skin, intense itching, inflammatory skin lesions and a considerable impact on quality of life. Moisturisers are considered an integral part of treatment.
J van Zuuren E et al. Emollients and moisturisers for eczema. Cochrane Reviews, 2017, Issue 2. Art. No.: CD012119.DOI: 10.1002/14651858. CD012119.pub2. This review contains 77 studies involving 6603 participants.